Holen Sie sich die Stockscreener-App
117.17
1.60%
-1.91
Handel nachbörslich:
119.22
2.05
+1.75%
Schlusskurs vom Vortag:
$119.08
Offen:
$117.49
24-Stunden-Volumen:
466.19K
Relative Volume:
0.84
Marktkapitalisierung:
$3.85B
Einnahmen:
$787.85M
Nettoeinkommen (Verlust:
$-27.78M
KGV:
-135.05
EPS:
-0.8676
Netto-Cashflow:
$18.75M
1W Leistung:
+7.30%
1M Leistung:
-1.50%
6M Leistung:
-24.17%
1J Leistung:
-16.41%
1-Tages-Spanne:
$116.50
$120.11
1-Wochen-Bereich:
$110.81
$123.75
52-Wochen-Spanne:
$100.85
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Holdings Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
117.17 | 3.69B | 787.85M | -27.78M | 18.75M | -0.8676 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-09-23 | Eingeleitet | Evercore ISI | In-line |
| 2025-08-20 | Eingeleitet | BofA Securities | Buy |
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Holdings Inc Aktie (IRTC) Neueste Nachrichten
IRTC|iRhythm Technologies Inc|Price:112.260|Chg%:+3.060 - TradingKey
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring A 62% Upside Potential - DirectorsTalk Interviews
iRhythm Holdings, Inc. Revenue Breakdown – MUN:I25 - TradingView
iRhythm Technologies Inc (IRTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iRhythm Technologies Inc (IRTC) Institutional Confidence - TradingKey
IRTC Initiates Coverage On iRhythm Holdings -- Rating Overweight - GuruFocus
Stephens Initiates iRhythm Technologies at Overweight With $160 Price Target - marketscreener.com
IRTC5766242 Bond Coupon Profile — Rate & Payments - TradingView
IRTC5766242 Bond Profile — Key Metrics - TradingView
IRTC6025550 Bond Profile — Key Metrics - TradingView
ETFs Investing in iRhythm Holdings, Inc. Stocks - TradingView
symbol__ Stock Quote Price and Forecast - CNN
IRTC Q1 2026 Earnings: Surprise EPS Beat Drives Modest Share Gains Despite Revenue UncertaintyTangible Book Value - dars.gov.et
iRhythm Holdings to report Q2 2026 results on Aug 6 - scanx.trade
iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026 - The Manila Times
IRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026 - marketscreener.com
iRhythm’s Q2 Results Call Will Be Live After Aug. 6 Close - Stock Titan
IRTC Maintained by Truist Securities -- Price Target Lowered to $160 - GuruFocus
Truist Adjusts Price Target on iRhythm Technologies to $160 From $174, Maintains Buy Rating - marketscreener.com
Truist Adjusts Price Target on IRhythm Technologies to $160 From $174, Maintains Buy Rating - Moomoo
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Merck & Company (MRK) and Viking Therapeutics (VKTX) - The Globe and Mail
BTIG Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $185 - Moomoo
iRhythm (IRTC) Removed from Conviction List but Rating Remains P - GuruFocus
IRhythm Holdings, Inc. (IRTC): Investor Outlook Reveals 53% Potential Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
Tax-related share sale by iRhythm (IRTC) EVP after RSU vesting - Stock Titan
iRhythm (IRTC) chief medical officer sells 1,423 shares for RSU tax withholding - Stock Titan
IRhythm Holdings, Inc. (IRTC) Stock Analysis: A 41% Potential Upside Beckons Investors - DirectorsTalk Interviews
Does iRhythm (IRTC) Balancing a Revenue Beat With In-Line Guidance Recast Its AI Cardiac Story? - Sahm
iRhythm Holdings, Inc. (IRTC) reports Q1 loss, tops revenue estimates - MSN
Q1 Earnings Roundup: iRhythm (NASDAQ:IRTC) And The Rest Of The Patient Monitoring Segment - Yahoo Finance
iRhythm (IRTC) Q1 2026 Earnings: EPS Beats Expectations by 47% Despite Continued LossPost-Earnings Drift - dars.gov.et
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling A Promising 50% Upside Potential - DirectorsTalk Interviews
Why iRhythm Holdings (IRTC) Is Up 10.8% After Strong Results and New DOJ InquiryAnd What's Next - Sahm
Enterprise value to EBITDA forward of iRhythm Holdings, Inc. – NASDAQ:IRTC - TradingView
I25 Forecast — Price Target — Prediction for 2027 - TradingView
iRhythm Holdings, Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Q1 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
Enterprise value to revenue forward of iRhythm Holdings, Inc. – NASDAQ:IRTC - TradingView
IRTC Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of iRhythm Holdings, Inc. – NASDAQ:IRTC - TradingView
Price to book forward of iRhythm Holdings, Inc. – NASDAQ:IRTC - TradingView
Price to sales forward of iRhythm Holdings, Inc. – DUS:I25 - TradingView
Price to earnings forward of iRhythm Holdings, Inc. – DUS:I25 - TradingView
iRhythm Holdings, Inc. Actuals & Estimates (NASDAQ:IRTC) - TradingView
iRhythm Holdings (IRTC) Dropped Despite Posting Beat-And-Raise Results - Yahoo Finance
IRTC Reiterated by BTIG -- Price Target Maintained at $185 - GuruFocus
iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a 70.98% Potential Upside for Astute Investors - DirectorsTalk Interviews
BTIG reiterates Buy on iRhythm, maintains $185 price target - scanx.trade
Top 3 health care stocks you'll regret missing in Q2 - MSN
iRhythm Holdings (IRTC) Advances on Positive Momentum: Key Levels to WatchMonthly Profile - dars.gov.et
Heart Monitoring Device Manufacturer Discloses Cyberattack; Data Breach - The HIPAA Journal
Finanzdaten der Irhythm Holdings Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Irhythm Holdings Inc-Aktie (IRTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Freeman Sean Clinton | EVP, Strategy & Corp Devt |
Jul 02 '26 |
Sale |
124.71 |
918 |
114,484 |
13,641 |
| Shrishrimal Sumi | EVP, Chief Risk Officer |
Jun 02 '26 |
Sale |
108.19 |
1,716 |
185,652 |
40,287 |
| Rosenbaum Marc Wade | Chief Accounting Officer |
Jun 02 '26 |
Sale |
108.19 |
729 |
78,870 |
16,155 |
| TALWALKAR ABHIJIT Y | Director |
May 11 '26 |
Buy |
10.71 |
5,312 |
56,892 |
25,611 |
| TALWALKAR ABHIJIT Y | Director |
May 11 '26 |
Sale |
117.93 |
5,312 |
626,430 |
20,299 |
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):